| Fc gamma receptors are expressed on human neuroblastoma cell lines: lack of correlation with N-myc oncogene activity. | neuroblastoma, |
| [Immunohistochemical studies of recessive oncogene p53 and N-myc oncogene expression in 7, 12 dimethylbenz (a) anthracene-induced rat ovarian tumors]. | ovarian, |
| Epstein-Barr virus (EBV) genomes and c-myc oncogene in oral Burkitt s lymphomas. | lymphoma, |
| Induction of thymus-reestablishing lymphoid tumors by a murine leukemia virus carrying the avian v-myc oncogene. | leukemia, |
| [Analysis of surface membrane antigens, cytoskeletal proteins and N-myc oncogene in pediatric solid malignant tumors, their diagnostic usefulness and relevant problems]. | pediatric, |
| Amplification of the c-myc proto-oncogene in human chondrosarcoma. | sarcoma, |
| Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations. | lung, |
| Preliminary study on oncogene product immunohistochemistry (c-erbB-2, c-myc, ras p21, EGFR) in breast pathology. | breast, |
| [The expression of C-myc oncogene in leukemia and its relationship to clinical symptoms]. | leukemia, |
| [Expression of c-myc and c-ki-ras oncogene in human pancreatic carcinoma]. | pancreatic, |
| CCK, bombesin, and carbachol stimulate c-fos, c-jun, and c-myc oncogene expression in rat pancreatic acini. | pancreatic, |
| Amplification of the c-myc oncogene in radiation-induced rat skin tumors as a function of linear energy transfer and dose. | skin, |
| Analysis of c-myc oncogene in human esophageal carcinoma: immunohistochemistry, in situ hybridization and northern and Southern blot studies. | esophageal, |
| N-myc oncogene expression in neuroblastoma is driven by Sp1 and Sp3. | neuroblastoma, |
| The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma. | endometrial, |
| Early overexpression of Cdk4 and possible role of KRF and c-myc in chewing tobacco mediated oral cancer development. | oral |
| Methylation status of c-myc oncogene in leukemic cells: hypomethylation in acute leukemia derived from myelodysplastic syndromes. | leukemia, |
| Lack of allelic preference in amplification and loss of the c-myc oncogene in methylcholanthrene-induced mouse sarcomas. | sarcoma, |
| C-myc oncoprotein expression and gene amplification in apocrine metaplasia and apocrine change within sclerosing adenosis of the breast. | breast, |
| C-myc oncogene expression in ocular melanomas. | skin, |